TriSalus Life Sciences (TLSI) Company Overview

Profile

Full Name:

TriSalus Life Sciences, Inc.

Sector:

Healthcare

Industry:

Medical Devices

Country:

United States

IPO:

February 8, 2021

Indexes:

Not included

Website:

http://trisaluslifesci.com

Description:

TriSalus Life Sciences (TLSI) focuses on developing innovative treatments for cancer. They specialize in using advanced drug delivery systems to improve the effectiveness of therapies, particularly for difficult-to-treat tumors. Their goal is to enhance patient outcomes and provide new options for cancer care.

Key Details

Price

$5.65

Market Cap

$172.29 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$18.51 M(+49.31% YoY)

Annual EPS

-$6.73(+95.83% YoY)

PE Ratio

-

Annual ROE

227.61%

Annual Debt To Equity

0.00

Beta

0.34

Events Calendar

Earnings

Next earnings date:

Mar 27, 2025

Recent quarterly earnings:

Nov 14, 2024

Recent annual earnings:

Apr 1, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 13, 25 Lake Street
Buy
Jan 24, 25 Roth MKM
Buy
Dec 17, 24 Cantor Fitzgerald
Overweight
Nov 15, 24 Canaccord Genuity
Buy
Nov 11, 24 Roth MKM
Buy
Oct 25, 24 Northland Capital Markets
Outperform
Sep 16, 24 Oppenheimer
Outperform
Jun 27, 24 Canaccord Genuity
Buy
May 30, 24 Canaccord Genuity
Buy
May 10, 24 JonesTrading
Buy

Screeners with TLSI included

Growing Shares Outstanding
US stocks
Biggest stock losers today
Most recommended stocks
Best performing stocks last 3 months
Stocks above SMA 50
Stocks below analysts price target
Healthcare sector
All stocks
Small cap stocks

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$5.65
TLSI price is $5.65

Price All-time High

$11.51
TLSI price is currently -50.91% below its historical high of $11.51

Price Analysts Target

$11.00
TLSI price is currently -48.64% lower than the consensus analysts' forecast

Price Most Recent Change

-5.83%
TLSI price was down -5.83% on Mar 4, 2025

Price YTD Change

+12.77%
TLSI price is up +12.77% since January 1st

Price 3-Year Change

-43.27%
TLSI price is down -43.27% over the past 3 years

Market cap

Market Cap

$172.29 M
TLSI market capitalization is $172.29 million

Market Cap 3-Year Change

-
TLSI market capitalization 3-year change is unknown

Market Cap All-time High

$302.91 M
TLSI market capitalization is currently -43.12% below its historical high of $302.91 million

Market Cap Sector Rank

54.16%
TLSI market capitalization is higher than 54.16% of companies in Healthcare sector

Technical

Beta

0.34
TLSI beta is 0.34

200-day SMA

$5.27
TLSI price is currently +7.30% above its 200-day simple moving average

14-day RSI

58.75
TLSI 14-day relative strength index is 58.75

30-day Relative Volume

0.81
TLSI 30-day relative volume is 0.81

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$18.51 M
TLSI annual revenue is $18.51 million

Annual Revenue Analysts Estimate

$29.37 M
TLSI annual revenue is currently -36.97% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

+49.31%
TLSI annual revenue is up +49.31% year-on-year

Annual Revenue Sector Rank

35.47%
TLSI annual revenue is higher than 35.47% of companies in Healthcare sector

Profit

Annual Gross Profit

$15.91 M
TLSI annual gross profit is $15.91 million

Annual Gross Margin

85.93%
TLSI annual gross profit margin is 85.93%

Annual Operating Profit

-$54.15 M
TLSI annual operating income is -$54.15 million

Annual Operating Margin

-292.53%
TLSI annual operating profit margin is -292.53%

Annual Net Income

-$59.04 M
TLSI annual net profit is -$59.04 million

Annual Net Margin

-318.93%
TLSI annual net profit margin is -318.93%

EPS

Annual EPS

-$6.73
TLSI annual earnings per share is -$6.73

Annual EPS Analysts Estimate

-$1.27
TLSI annual earnings per share is currently +429.92% higher than the consensus analysts' forecast

Annual EPS 1-Year Change

+95.83%
TLSI annual earnings per share is up +95.83% year-on-year

Annual EPS Sector Rank

18.64%
TLSI annual earnings per share is higher than 18.64% of companies in Healthcare sector

ROA & ROE

Annual ROA

-247.44%
TLSI annual return on assets is -247.44%

Annual ROE

227.61%
TLSI annual return on equity is 227.61%

EBIT & EBITDA

Annual EBIT

-$59.01 M
TLSI annual earnings before interest & taxes is -$59.01 million

Annual EBITDA

-$58.31 M
TLSI annual EBITDA is -$58.31 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
TLSI price to earnings ratio value is unknown

PE Ratio Sector Rank

-
TLSI price to earnings ratio is unknown

PB Ratio

PB Ratio

-8.43
TLSI price to book ratio is -8.43

PB Ratio Sector Rank

2.81%
TLSI price to book ratio is higher than 2.81% of companies in Healthcare sector

PS Ratio

PS Ratio

6.41
TLSI price to sales ratio is 6.41

PS Ratio Sector Rank

68.71%
TLSI price to sales ratio is higher than 68.71% of companies in Healthcare sector

Enterprise value

Enterprise Value

$184.45 M
TLSI enterprise value is $184.45 million

Enterprise Value Sector Rank

56.5%
TLSI enterprise value is higher than 56.5% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-3.52
TLSI EV/EBITDA is -3.52

EV/EBITDA Sector Rank

26.96%
TLSI EV/EBITDA is higher than 26.96% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

1.42
TLSI annual current ratio is 1.42

Annual Quick Ratio

1.25
TLSI annual quick ratio is 1.25

Leverage

Annual Debt To Equity

0.00
TLSI annual debt to equity ratio is 0.00

Annual Interest Coverage Ratio

-3688.31
TLSI annual interest coverage ratio is -3688.31

Risk & Stability

Piotroski F-Score

2
TLSI piotroski f-score is 2

Altman Z-Score

-18.08
TLSI altman z-score is -18.08

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$25.73 M
TLSI annual total assets is $25.73 million

Annual Non Current Assets

$4.86 M
TLSI annual long term assets is $4.86 million

Annual Current Assets

$20.86 M
TLSI annual total current assets is $20.86 million

Annual Cash & Cash Equivalents

$11.78 M
TLSI annual cash & cash equivalents is $11.78 million

Equity

Annual Book Value

-$25.94 M
TLSI annual book value is -$25.94 million

Annual Working Capital

$6.17 M
TLSI annual working capital is $6.17 million

Liabilities

Annual Total Liabilities

$51.66 M
TLSI annual total liabilities is $51.66 million

Annual Total Long Term Liabilities

$36.98 M
TLSI annual total long term liabilities is $36.98 million

Annual Current Liabilities

$14.69 M
TLSI annual total current liabilities is $14.69 million

Annual Accounts Payable

$3.39 M
TLSI annual accounts payable is $3.39 million

Debt

Annual Total Debt

$1.59 M
TLSI annual total debt is $1.59 million

Annual Total Debt 1-Year Change

-18.75%
TLSI annual total debt is down -18.75% year-on-year

Annual Long Term Debt

$1.24 M
TLSI annual long term debt is $1.24 million

Annual Short Term Debt

$351.00 K
TLSI annual short term debt is $351.00 thousand

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$72.66 M
TLSI annual total expenses is $72.66 million

Annual Operating Expenses

$70.06 M
TLSI annual total operating expenses is $70.06 million

Annual Cost Of Goods Sold

$2.60 M
TLSI annual cost of goods sold is $2.60 million

Annual SGA

$40.55 M
TLSI annual SGA is $40.55 million

Annual D&A

$702.00 K
TLSI annual depreciation & amortization is $702.00 thousand

Annual Interest Expense

$16.00 K
TLSI annual interest expense is $16.00 thousand

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$50.05 M
TLSI annual cash flow from operations is -$50.05 million

Annual CFO 1-Year Change

-54.88%
TLSI annual cash flow from operations is down -54.88% year-on-year

Annual CFI

-$2.12 M
TLSI annual cash flow from investing activities is -$2.12 million

Annual CFI 1-Year Change

-18.76%
TLSI annual cash flow from investing activities is down -18.76% year-on-year

Annual CFF

$54.63 M
TLSI annual cash flow from financing activities is $54.63 million

Annual CFF 1-Year Change

+305.8%
TLSI annual cash flow from financing activities is up +305.8% year-on-year

Free CashFlow

Annual FCF

-$51.17 M
TLSI annual free cash flow is -$51.17 million

Annual FCF 1-Year Change

-54.58%
TLSI annual free cash flow is down -54.58% year-on-year

CAPEX

Annual CAPEX

$1.12 M
TLSI annual capital expenditures is $1.12 million

Annual CAPEX 1-Year Change

+42.62%
TLSI annual capital expenditures is up +42.62% year-on-year

Institutional Ownership

Similar stocks

STXS logo
Stereotaxis (STXS)
INMB logo
INmune Bio (INMB)
CCCC logo
C4 Therapeutics (CCCC)
MNPR logo
Monopar Therapeutics (MNPR)
Atlantic International (ATLN)
Contineum Therapeutics Class A (CTNM)
GNFT logo
Genfit SA (GNFT)
BWAY logo
BrainsWay (BWAY)
PLX logo
Protalix BioTherapeutics (PLX)

FAQ

  • What is the ticker symbol for TriSalus Life Sciences?
  • Does TriSalus Life Sciences pay dividends?
  • What sector is TriSalus Life Sciences in?
  • What industry is TriSalus Life Sciences in?
  • What country is TriSalus Life Sciences based in?
  • When did TriSalus Life Sciences go public?
  • Is TriSalus Life Sciences in the S&P 500?
  • Is TriSalus Life Sciences in the NASDAQ 100?
  • Is TriSalus Life Sciences in the Dow Jones?
  • When was TriSalus Life Sciences's last earnings report?
  • When does TriSalus Life Sciences report earnings?
  • Should I buy TriSalus Life Sciences stock now?

What is the ticker symbol for TriSalus Life Sciences?

The ticker symbol for TriSalus Life Sciences is NASDAQ:TLSI

Does TriSalus Life Sciences pay dividends?

No, TriSalus Life Sciences does not pay dividends

What sector is TriSalus Life Sciences in?

TriSalus Life Sciences is in the Healthcare sector

What industry is TriSalus Life Sciences in?

TriSalus Life Sciences is in the Medical Devices industry

What country is TriSalus Life Sciences based in?

TriSalus Life Sciences is headquartered in United States

When did TriSalus Life Sciences go public?

TriSalus Life Sciences's initial public offering (IPO) was on February 8, 2021

Is TriSalus Life Sciences in the S&P 500?

No, TriSalus Life Sciences is not included in the S&P 500 index

Is TriSalus Life Sciences in the NASDAQ 100?

No, TriSalus Life Sciences is not included in the NASDAQ 100 index

Is TriSalus Life Sciences in the Dow Jones?

No, TriSalus Life Sciences is not included in the Dow Jones index

When was TriSalus Life Sciences's last earnings report?

TriSalus Life Sciences's most recent earnings report was on Nov 14, 2024

When does TriSalus Life Sciences report earnings?

The next expected earnings date for TriSalus Life Sciences is Mar 27, 2025

Should I buy TriSalus Life Sciences stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions